NCT02896257View on ClinicalTrials.gov

De-implementing Inhaled Steroids to Improve Care and Safety in COPD

NACompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

September 6, 2016

Primary Completion Date

July 29, 2019

Study Completion Date

June 30, 2021

Conditions
Treatment of Chronic Obstructive Pulmonary Disease
Interventions
OTHER

Guideline treatment recommendations

Patient-tailored E-consult, orders and rationale to discontinue inhaled corticosteroids and discontinue or receive other COPD related care.

Trial Locations (2)

01730-1114

VA Bedford HealthCare System, Bedford, MA, Bedford

98108-1532

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02896257 - De-implementing Inhaled Steroids to Improve Care and Safety in COPD | Biotech Hunter | Biotech Hunter